Shares in Bouygues do not show any sign of a slowdown in the ascending dynamic. Investors could bet on a continuation of the underlying trend. Investors have an opportunity to buy the stock and target the € 47.5.
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
The company has solid fundamentals for a short-term investment strategy.
The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.55 for the 2017 fiscal year.
The company is one of the best yield companies with high dividend expectations.
Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Within the weekly time frame the stock shows a bullish technical configuration above the support level at 38.82 EUR
The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
According to Thomson-Reuters' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.